UpdatesGeneral Updates
Board approved Q1 results: Revenue INR 797.7 Cr, Profit INR 169.5 Cr.
Dr. Lal Path Labs Ltd.LALPATHLAB · Filed with the exchange
Interim dividend declared at INR 5/share.
Acquisitions include SDCPL for INR 20 Cr, 80% of Ghana's SHL for INR 38 Cr, and 30% of Neuome for INR 3.5 Cr.
No comments yet. Be the first.